Browsing Tag

$INM

InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of…

Eli Pacheco Jun 14, 2022 0

VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing…

Business

InMed Pharmaceuticals Inc. (INM) Reports Q2 Loss, Tops Revenue Estimates

Dustin Moskovitz Feb 15, 2022 0

This story originally appeared on Zacks InMed Pharmaceuticals Inc. (INM) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a…

Health

InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of…

Eli Pacheco Dec 20, 2021 0

VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and…